(Q73781366)
Statements
A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects (English)
J S Lambert
M Keefer
M J Mulligan
D Schwartz
J Mestecky
K Weinhold
C Smith
R Hsieh
Z Moldoveanu
P Fast
B Forrest